273 related articles for article (PubMed ID: 21885726)
1. Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy.
Takeda A; Kunieda E; Ohashi T; Aoki Y; Oku Y; Enomoto T; Nomura K; Sugiura M
Chest; 2012 Apr; 141(4):858-866. PubMed ID: 21885726
[TBL] [Abstract][Full Text] [Related]
2. Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereotactic body radiotherapy (SBRT) in patients with lung tumors.
Takeda A; Ohashi T; Kunieda E; Enomoto T; Sanuki N; Takeda T; Shigematsu N
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):685-90. PubMed ID: 20510193
[TBL] [Abstract][Full Text] [Related]
3. Reassessment of declines in pulmonary function ≥1 year after stereotactic body radiotherapy.
Takeda A; Enomoto T; Sanuki N; Handa H; Aoki Y; Oku Y; Kunieda E
Chest; 2013 Jan; 143(1):130-137. PubMed ID: 22722234
[TBL] [Abstract][Full Text] [Related]
4. Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection.
Hayes JT; David EA; Qi L; Chen AM; Daly ME
Clin Lung Cancer; 2015 Sep; 16(5):379-84. PubMed ID: 25737143
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary dose-volume predictors of radiation pneumonitis following stereotactic body radiation therapy.
Harder EM; Park HS; Chen ZJ; Decker RH
Pract Radiat Oncol; 2016; 6(6):e353-e359. PubMed ID: 27156424
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Radiation Pneumonitis After Stereotactic Body Radiotherapy: Effect of Pulmonary Emphysema Quantitated Using CT Images.
Yamamoto T; Kadoya N; Sato Y; Matsushita H; Umezawa R; Kubozono M; Ishikawa Y; Kozumi M; Takahashi N; Morishita Y; Katagiri Y; Sato K; Ito K; Takeda K; Jingu K
Clin Lung Cancer; 2018 Jan; 19(1):e85-e90. PubMed ID: 28655592
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.
Rancati T; Ceresoli GL; Gagliardi G; Schipani S; Cattaneo GM
Radiother Oncol; 2003 Jun; 67(3):275-83. PubMed ID: 12865175
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer.
Nakamura M; Nishimura H; Nakayama M; Mayahara H; Uezono H; Harada A; Hashimoto N; Ejima Y; Ishihara T; Sasaki R
Br J Radiol; 2016 Dec; 89(1068):20160560. PubMed ID: 27805837
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy.
Hara Y; Takeda A; Eriguchi T; Sanuki N; Aoki Y; Nishimura S; Enomoto T; Shinkai M; Kawana A; Kaneko T
J Radiat Res; 2016 Jan; 57(1):62-7. PubMed ID: 26487713
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy.
Harder EM; Park HS; Nath SK; Mancini BR; Decker RH
Pract Radiat Oncol; 2015; 5(6):e643-9. PubMed ID: 26412341
[TBL] [Abstract][Full Text] [Related]
11. Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis.
Uchida Y; Tsugawa T; Tanaka-Mizuno S; Noma K; Aoki K; Shigemori W; Nakagawa H; Kinose D; Yamaguchi M; Osawa M; Ogawa E; Nakano Y
Radiat Oncol; 2017 Oct; 12(1):160. PubMed ID: 28969651
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
[TBL] [Abstract][Full Text] [Related]
13. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
Ren C; Ji T; Liu T; Dang J; Li G
Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
[TBL] [Abstract][Full Text] [Related]
14. Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience.
Henkenberens C; Janssen S; Lavae-Mokhtari M; Leni K; Meyer A; Christiansen H; Bremer M; Dickgreber N
Radiat Oncol; 2016 Feb; 11():12. PubMed ID: 26830686
[TBL] [Abstract][Full Text] [Related]
15. Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients.
Saha A; Beasley M; Hatton N; Dickinson P; Franks K; Clarke K; Jain P; Teo M; Murray P; Lilley J
Radiother Oncol; 2021 Mar; 156():153-159. PubMed ID: 33333139
[TBL] [Abstract][Full Text] [Related]
16. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).
Glick D; Lyen S; Kandel S; Shapera S; Le LW; Lindsay P; Wong O; Bezjak A; Brade A; Cho BCJ; Hope A; Sun A; Giuliani M
Clin Lung Cancer; 2018 Mar; 19(2):e219-e226. PubMed ID: 29066051
[TBL] [Abstract][Full Text] [Related]
17. Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours.
Takeda A; Ohashi T; Kunieda E; Sanuki N; Enomoto T; Takeda T; Oku Y; Shigematsu N
Br J Radiol; 2012 May; 85(1013):636-42. PubMed ID: 22253343
[TBL] [Abstract][Full Text] [Related]
18. Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer.
Matsuo Y; Shibuya K; Nakamura M; Narabayashi M; Sakanaka K; Ueki N; Miyagi K; Norihisa Y; Mizowaki T; Nagata Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e545-9. PubMed ID: 22436782
[TBL] [Abstract][Full Text] [Related]
19. Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours.
Okubo M; Itonaga T; Saito T; Shiraishi S; Mikami R; Nakayama H; Sakurada A; Sugahara S; Koizumi K; Tokuuye K
Br J Radiol; 2017 May; 90(1073):20160508. PubMed ID: 28195507
[TBL] [Abstract][Full Text] [Related]
20. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.
Barriger RB; Forquer JA; Brabham JG; Andolino DL; Shapiro RH; Henderson MA; Johnstone PA; Fakiris AJ
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):457-62. PubMed ID: 21035956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]